Results 201 to 210 of about 735,599 (336)

Mitochondrial Diseases: Molecular Pathogenesis and Therapeutic Advances. [PDF]

open access: yesMedComm (2020)
Mei J   +6 more
europepmc   +1 more source

Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases. [PDF]

open access: yesJ Pers Med, 2023
Cadoni G   +6 more
europepmc   +1 more source

The Case of a 25‐Year‐Old Woman With Isolated Head Tremor

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study reported a 25‐year‐old woman with isolated head tremors as the main manifestation, along with type 1 diabetes, bilateral hearing loss, and leukoencephalopathy, who was diagnosed with mitochondrial disease due to a single large mtDNA deletion (m.8647‐16082del).
Ying Zhao   +5 more
wiley   +1 more source

Examining saliva proteomic dynamics in mitochondrial diseases from a perspective of intrinsic health. [PDF]

open access: yesSci Rep
Zhao J   +7 more
europepmc   +1 more source

Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating Scale

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The placebo response in clinical trials in ataxias complicates outcome interpretation and potentially obscures genuine treatment effects. We analyzed placebo group data from past trials in Friedreich Ataxia and observed notable responses in appendicular items, in contrast to minimal changes in axial function, as measured by respective ...
Christian Rummey   +2 more
wiley   +1 more source

Animal Models of Mitochondrial Diseases Associated with Nuclear Gene Mutations. [PDF]

open access: yesActa Naturae, 2023
Averina OA   +3 more
europepmc   +1 more source

Multi‐Omics Integration for Advancing Glioma Precision Medicine

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Gliomas are among the most malignant and aggressive tumors of the central nervous system, characterized by the absence of early diagnostic markers, poor prognosis, and a lack of effective treatments. Advances in high‐throughput technologies have facilitated a refined molecular classification of gliomas, incorporating genetic features. However,
Maria Guarnaccia   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy